Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
25.70
-0.60 (-2.28%)
Sep 26, 2024, 4:00 PM EDT - Market closed
Bicara Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 |
| Sep '24 Sep 26, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 1,398 | - | - |
| Enterprise Value | 1,562 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | - |
| Debt / FCF Ratio | -0.01 | -0.01 | - |
| Quick Ratio | 12.69 | 15.28 | 0.17 |
| Current Ratio | 12.83 | 15.32 | 0.21 |
| Return on Equity (ROE) | - | -51.67% | - |
| Return on Assets (ROA) | - | -20.72% | - |
| Return on Capital (ROIC) | - | -24.70% | - |
| Buyback Yield / Dilution | -35.20% | - |
| Total Shareholder Return | -35.20% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.